ICAM1 and type 2 diabetes mellitus: When serum was incubated with HUVECs, the plasma from T2DM/AMI significantly increased the levels of miR‐499 (Figure S4D), levels of ICAM‐1(Figure S4E) and levels of MCP‐1 (Figure S4F) in HUVECs compared to that from T2DM.